Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study ; volume:37 ; number:8 ; day:9 ; month:8 ; year:2023 ; pages:715-723 ; date:8.2023
CNS drugs ; 37, Heft 8 (9.8.2023), 715-723, 8.2023
- Creator
-
Castro, Meredith
Wilkinson, Samuel T.
Al Jurdi, Rayan K.
Petrillo, Mary Pat
Zaki, Naim
Borentain, Stephane
Fu, Dong Jing
Turkoz, Ibrahim
Sun, Liping
Brown, Brianne
Cabrera, Patricia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-023-01026-3
- URN
-
urn:nbn:de:101:1-2023110414261160623355
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Castro, Meredith
- Wilkinson, Samuel T.
- Al Jurdi, Rayan K.
- Petrillo, Mary Pat
- Zaki, Naim
- Borentain, Stephane
- Fu, Dong Jing
- Turkoz, Ibrahim
- Sun, Liping
- Brown, Brianne
- Cabrera, Patricia
- SpringerLink (Online service)
Other Objects (12)
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
The Lighthouse completed
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
The Lighthouse completed
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
The Lighthouse completed
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials